Market Closed -
OTC Markets
12:48:05 01/05/2024 am IST
5-day change
1st Jan Change
1.2
USD
+471.16%
-.--%
+471.16%
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
March 19, 2019 at 09:44 pm IST
Bioethics, Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced operating loss was USD 53,981 compared to USD 48,220 a year ago. Net loss was USD 73,539 compared to USD 64,223 a year ago.
Bioethics, Ltd. Appoints Doug Morris as A Member of Board of Directors
30/04
CI
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
12/04
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
15/11
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
10/23/10
CI
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
20/23/20
CI
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
18/23/18
CI
Bioethics, Ltd. Auditor Raises 'Going Concern' Doubt
17/23/17
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
21/22/21
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
15/22/15
CI
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
24/22/24
CI
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
15/22/15
CI
Bioethics, Ltd. Auditor Raises 'Going Concern' Doubt
15/22/15
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
19/21/19
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
23/21/23
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
19/20/19
CI
XCR Diagnostics, Inc. entered into a non-binding term sheet to acquire Bioethics, Ltd. in a reverse merger transaction for approximately $110 million.
31/20/31
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
28/20/28
CI
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
15/20/15
CI
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
10/20/10
CI
Bioethics, Ltd. Announces Director Resignations
06/20/06
CI
Bioethics, Ltd. Announces Executive Changes
24/20/24
CI
Bioethics, Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
15/19/15
CI
Bioethics, Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
15/19/15
CI
Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019
16/19/16
CI
Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
19/19/19
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Bioethics, Ltd. is a shell company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The Company has not commenced any operations nor generated any revenue.
More about the company
1st Jan change
Capi.
+471.16% 1.36M +180.51% 8.67B +2.29% 983M +41.91% 883M +26.17% 825M +1.92% 665M +9.52% 664M -.--% 600M +9.17% 530M -.--% 500M
Shell Companies
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
BIOETHICS, LTD. 
